TMPRSS2 and prostate cancer: To illustrate how INTEGRATE-Vis works we focused on a prostate cancer patient harboring the most prevalent gene fusion, TMPRSS2-ERG, that results in the marked increase in the expression of the oncogenic transcription factor ERG (Fig. 2).